References

Breast Cancer

10.1016/s0140-6736(16)31891-8 · 2017 · External reference

Current Treatment Landscape for Early Triple‐Negative Breast Cancer (TNBC)

10.3390/jcm12041524 · 2023 · External reference

Triple‐Negative Breast Cancer Therapeutic Resistance: Where Is the Achilles' Heel?

10.1016/j.canlet.2020.10.016 · 2021 · External reference

Triple‐Negative Breast Cancer Has Worse Overall Survival and Cause‐Specific Survival Than Non‐Triple‐Negative Breast Cancer

10.1007/s10549-016-4059-6 · 2017 · External reference

Triple‐Negative Breast Cancer: Epidemiology, Molecular Mechanisms, and Modern Vaccine‐Based Treatment Strategies

10.1016/j.bcp.2023.115545 · 2023 · External reference

Cryo‐EM Structures Reveal That RFC Recognizes Both the 3'‐ and 5'‐DNA Ends to Load PCNA Onto Gaps for DNA Repair

10.7554/elife.77469 · 2022 · External reference

Eukaryotic Clamp Loaders and Unloaders in the Maintenance of Genome Stability

10.1038/s12276-020-00533-3 · 2020 · External reference

Multifaceted Regulation and Functions of Replication Factor C family in Human Cancers

2018 · External reference

Redox Biology in Normal Cells and Cancer: Restoring Function of the Redox/Fyn/c‐Cbl Pathway in Cancer Cells Offers New Approaches to Cancer Treatment

10.1016/j.freeradbiomed.2014.10.860 · 2015 · External reference

BTF3 Confers Oncogenic Activity in Prostate Cancer through Transcriptional Upregulation of Replication Factor C

10.1038/s41419-020-03348-2 · 2021 · External reference

The PCNA‐RFC Families of DNA Clamps and Clamp Loaders

10.1016/s0079-6603(04)78006-x · 2004 · External reference

Identification of RFC4 as a Potential Biomarker for Pan‐Cancer Involving Prognosis, Tumour Immune Microenvironment and Drugs

10.1111/jcmm.18478 · 2024 · External reference

Expanding the Genetic and Phenotypic Landscape of Replication Factor C Complex‐Related Disorders: RFC4 Deficiency Is Linked to a Multisystemic Disorder

10.1016/j.ajhg.2024.07.008 · 2024 · External reference

The Genomic Landscape of Mucinous Breast Cancer

10.1093/jnci/djy216 · 2019 · External reference

TRIM Family Contribute to Tumorigenesis, Cancer Development, and Drug Resistance

10.1186/s40164-022-00322-w · 2022 · External reference

TRIM E3 Ubiquitin Ligases in Rare Genetic Disorders

10.1007/978-3-030-38266-7_14 · 2020 · External reference

KAP1/TRIM28: Transcriptional Activator and/or Repressor of Viral and Cellular Programs?

10.3389/fcimb.2022.834636 · 2022 · External reference

TRIM28 in Cancer and Cancer Therapy

10.3389/fgene.2024.1431564 · 2024 · External reference

ZNF689 Deficiency Promotes Intratumor Heterogeneity and Immunotherapy Resistance in Triple‐Negative Breast Cancer

10.1038/s41422-023-00909-w · 2024 · External reference

TRIM28 Promotes the Escape of Gastric Cancer Cells from Immune Surveillance by Increasing PD‐L1 Abundance

10.1038/s41392-023-01450-3 · 2023 · External reference

Rap1 Signalling: Adhering to New Models

10.1038/35073073 · 2001 · External reference

TRIM28 Secures Skeletal Stem Cell Fate During Skeletogenesis by Silencing Neural Gene Expression and Repressing GREM1/AKT/mTOR Signaling Axis

10.1016/j.celrep.2023.112012 · 2023 · External reference

An RFC4/Notch1 Signaling Feedback Loop Promotes NSCLC Metastasis and Stemness

10.1038/s41467-021-22971-x · 2021 · External reference

HAMPLE: Deciphering TF‐DNA Binding Mechanism in Different Cellular Environments by Characterizing Higher‐Order Nucleotide Dependency

10.1093/bioinformatics/btad299 · 2023 · External reference

TRIM28‐Mediated Nucleocapsid Protein SUMOylation Enhances SARS‐CoV‐2 Virulence

10.1038/s41467-023-44502-6 · 2024 · External reference

Cancer Associated Fibroblast Derived SLIT2 Drives Gastric Cancer Cell Metastasis by Activating NEK9

10.1038/s41419-023-05965-z · 2023 · External reference

TRIM28 is a Transcriptional Activator of the Mutant TERT Promoter in Human Bladder Cancer

10.1073/pnas.2102423118 · 2021 · External reference

TRIM28 Inhibits Alternative Lengthening of Telomere Phenotypes by Protecting SETDB1 from Degradation

10.1186/s13578-021-00660-y · 2021 · External reference

E3 Ligase TRIM28 Promotes Anti‐PD‐1 Resistance in Non‐Small Cell Lung Cancer by Enhancing the Recruitment of Myeloid‐Derived Suppressor Cells

10.1186/s13046-023-02862-3 · 2023 · External reference

The Type I TGF‐Beta Receptor Engages TRAF6 to Activate TAK1 in a Receptor Kinase‐Independent Manner

10.1038/ncb1780 · 2008 · External reference

DDX39B K63‐Linked Ubiquitination Mediated by TRIM28 Promotes NSCLC Metastasis by Enhancing ECAD Lysosomal Degradation

10.1038/s41392-025-02305-9 · 2025 · External reference

Targets of B‐Cell Antigen Receptor Signaling: The Phosphatidylinositol 3‐Kinase/Akt/Glycogen Synthase Kinase‐3 Signaling Pathway and the Rap1 GTPase

10.1034/j.1600-065x.2000.00601.x · 2000 · External reference

The E3 Ligase SMURF1 Stabilizes p27 via UbcH7 Catalyzed K29‐Linked Ubiquitin Chains to Promote Cell Migration SMURF1‐UbcH7 K29 Ubiquitination of p27 and Cell Migration

10.1016/j.jbc.2024.105693 · 2024 · External reference

Mutated SPOP E3 Ligase Promotes 17betaHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression

10.1158/0008-5472.can-20-3258 · 2021 · External reference

The PARP1‐Siah1 Axis Controls HIV‐1 Transcription and Expression of Siah1 Substrates

10.1016/j.celrep.2018.05.084 · 2018 · External reference

Wnt/Ca2+ Signaling Pathway: A Brief Overview

10.1093/abbs/gmr079 · 2011 · External reference

A Rap/Phosphatidylinositol 3‐Kinase Pathway Controls Pseudopod Formation

10.1091/mbc.e09-03-0177 · 2010 · External reference

Phosphorylation of USP32 by CDK5 Regulates Rap1 Stability and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma

10.1038/s41388-024-03263-2 · 2025 · External reference

Targeting the PI3‐Kinase Pathway in Triple‐Negative Breast Cancer

10.1093/annonc/mdz133 · 2019 · External reference

Silencing TRAIP Suppresses Cell Proliferation and Migration/Invasion of Triple Negative Breast Cancer via RB‐E2F Signaling and EMT

10.1038/s41417-022-00517-7 · 2023 · External reference